Stock listing
NASDAQ:XYN Xynomic Pharmaceuticals Holdings Inc Stock
Follow Xynomic Pharmaceuticals Holdings Inc into a list and get an email when it puts out news.
Delisted NASDAQ:XYN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:XYN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Xynomic Pharmaceuticals Holdings Inc on 6ix
- Decks
- 4 decks · latest Sep 27, 2019
Where Xynomic Pharmaceuticals Holdings Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:XYN · This page · Delisted | NASDAQ | United States | USD |
| OTC:XYNO · Delisted | OTC | United States | USD |
| OTC:XYNPW · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2019) | Investor deck | 32 slides | Sep 27, 2019 |
| Investor Presentation (June 2019) | Investor deck | 24 slides | Jun 21, 2019 |
| Bison Capital Acquisition — SPAC Merger (January 2019) | SPAC merger | 33 slides | Jan 14, 2019 |
| Bison Capital Acquisition — SPAC Merger (September 2018) | SPAC merger | 34 slides | Sep 19, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Jiayuan Tong Other companies: Jin Medical International Ltd. (Director · Since at least Mar 18, 2026); Horizon Space Acquisition II Corp. (Director · Nov 12, 2024 – Nov 12, 2024 · Past); Tianyin Pharmaceutical Co Inc (CFO & Director & CBDO, Director · Apr 1, 2010 – May 28, 2014 · Past) | CEO and CFO, Director · Jun 19, 2017 – Jun 19, 2017 · Past |
| Peng Jin Other companies: Cineverse Corp. (Director · Nov 1, 2017 – Dec 12, 2018 · Past) | COO & Secretary · Jun 19, 2017 – Jun 19, 2017 · Past |
| Charles Vincent Prizzi | Director · Jun 19, 2017 – Jun 19, 2017 · Past |
| Ning Wang | Director · Jun 19, 2017 – Jun 19, 2017 · Past |
| Peidong Wu | Director · May 25, 2018 – May 25, 2018 · Past |
Log in to ask 6ix AI your own questions about Xynomic Pharmaceuticals Holdings Inc.